The increase was due to higher R&D, sales and marketing, and G&A costs in support of new customer and new product activities and a boost in post-COVID travel activities.

Nov 7, 2023 / receipt, needs a key / Mark McKechnie, CFO | earnings call 2023-11-07 | transcript 6a2659ba-7cf0-4a12-b0dd-3de6b4994d5f | chars 11836-12005 | segment 12

The increase was due to higher R&D, sales and marketing, and G&A costs in support of our new customer and new product activities, and a boost in the post-COVID travel.

Aug 4, 2023 / receipt, needs a key / Mark McKechnie, CFO | earnings call 2023-08-04 | transcript c9a37ede-1a49-4b1d-9d84-9e03a9bca3e8 | chars 10859-11026 | segment 11

So do you see your growth potentially benefiting from that over the next three years as well? actually i think for mature notes is pretty same right this moment you know that all the restrictions regulatory not limited to maternal right so i see that it's still everybody can sell so we're not a specific say they have to you know buy domestic whatever you know we're doing however because of the last two years three years you know the constraints applying and traveling and the people that's we will make our R&D team in Shanghai really make understanding, right? We still can't go in with service customer. Maybe that will give our customer kind of an advantage of our proximity on the center, manufacturer closing. I see that is a more big impact, right? So, I mean, I should say, I would say the customer still consider a faster tool pricing and also the, you know, stability of tool as a major consideration. and not just, you know, have to select domestic. I think that's a real fair market. We want to also share that market with other players in domestic and also outside China. It's really, you know, finally, it's really a solution game, right? Your cost, your service, your product, you know, quality. I look at that as more major.

Feb 24, 2023 / receipt, needs a key / David Wang, CEO | earnings call 2023-02-24 | transcript fa1ab855-666a-444b-a6d2-c7bc0b35dcd6 | chars 24231-25474 | segment 25